Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by GarryJan1on Feb 21, 2020 2:06pm
289 Views
Post# 30718730

Its always nice to see an Insider continually

Its always nice to see an Insider continuallysupport the stock by buying it on the market.

Insider Filings

Latest 10 SEDI filings for LIB within the last 6 months
 Amended Filing
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 10/20 Feb 7/20 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.040
Nov 26/19 Nov 26/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 25,000 $0.060
Oct 28/19 Oct 24/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 26,000 $0.040
Oct 11/19 Oct 10/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 35,000 $0.050
Oct 11/19 Oct 9/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 15,000 $0.050
Sep 23/19 Sep 23/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.075
Sep 17/19 Sep 13/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 34,000 $0.075
Sep 12/19 Sep 12/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 103,000 $0.075
Sep 11/19 Sep 11/19 Rascan, William Indirect Ownership Common Shares 10 - Acquisition in the public market 63,000 $0.075


<< Previous
Bullboard Posts
Next >>